Evergreen Therapeutics Achieves FDA Fast Track Designation for Novel SLE Treatment #United_States #Bethesda #Evergreen_Therapeutics #Neuropsychiatric_SLE #EG-501
@newsen.bsky.social@newsen.bsky.social
@newsen.bsky.socialEvergreen Therapeutics Achieves FDA Fast Track Designation for Novel SLE Treatment #United_States #Bethesda #Evergreen_Therapeutics #Neuropsychiatric_SLE #EG-501